Articles by Lorraine Carolan

All Medical News

ILTS 2016: Hepatocellular Carcinoma: To resect or transplant first? Professor Rene Adam (Paul Brousse Hospital, France) gives the key messages from the debate.

All Medical News

ILTS 2016 Report: Once-daily tacrolimus sees favourable results worldwide

by Thomas R. Collins: Leading transplant experts say they’ve had a good experience using the once-a-day tacrolimus regimen, reporting better patient adherence compared to the twice-a-day version, along… read more.

All Medical News

ILTS 2016: Risk of living donor transplants can be mitigated: Dr Leslie Lilly (Transplant Hepatologist, UHN Toronto General Hospital, ON, Canada). Also included associated article.

Risk of living donor transplants can be mitigated by Thomas R. Collins Making living donor transplants less risky through new and innovative approaches is the best way to… read more.

All Medical News

ILTS 2016: Professors John Lake (University of Minnesota, MN, USA) and John O’Grady (Kings College Hospital, London) discuss what's novel in immuno-suppression. Also associated article included on Immunosuppression.

Biomarkers emerging as guide on immunosuppression by Thomas R. Collins Using the right amount of immunosuppression treatment, but no more than necessary, is a challenge facing clinicians handling… read more.

All Medical News

ILTS 2016: Professors John Lake (University of Minnesota, MN, USA) and John O’Grady (Kings College Hospital, London) discuss what’s novel in immuno-suppression. Also associated article included on Immunosuppression.

Biomarkers emerging as guide on immunosuppression by Thomas R. Collins Using the right amount of immunosuppression treatment, but no more than necessary, is a challenge facing clinicians handling… read more.

All Medical News

ILTS 2016: Professor John O’Grady (Kings College Hospital, London) and Professor Sung-Gyu Lee (Ulsan University Medical School, Seoul, Korea) discuss their key messages in LDLT for the UK transplant community. Also included associated article entitled 'Done correctly, living donation success is possible'

Done correctly, living donation success is possible by Thomas R. Collins Life expectancy and quality of life measures tend to be quite high among live liver donors, generally… read more.

All Medical News

ILTS 2016: Professor John O’Grady (Kings College Hospital, London) and Professor Sung-Gyu Lee (Ulsan University Medical School, Seoul, Korea) discuss their key messages in LDLT for the UK transplant community. Also included associated article entitled ‘Done correctly, living donation success is possible’

Done correctly, living donation success is possible by Thomas R. Collins Life expectancy and quality of life measures tend to be quite high among live liver donors, generally… read more.

All Medical News

ILTS 2016 Highlights: ILTS President, Professor Jan Lerut (University Hospital St Luc, Brussels, Belgium), Professor Sung-Gyu Lee (Ulsan University Medical School, Seoul, Korea), Professor John Lake (University of Minnesota, MN, USA), Professor John O’Grady (Kings College Hospital, London) and Dr Leslie Lilly (Transplant Hepatologist, UHN Toronto General Hospital, ON, Canada) give their highlights from this year’s ILTS in Seoul.

All Medical News

ISH/BSH 2016: Professor Keith Stewart (Mayo Clinic, USA) discusses current dilemmas in MM, not least of which is how to manage patients with the ever growing number of new agents. He discusses the Mayo Clinic algorithm, whilst Professor Paul G. Richardson (Dana-Farber, USA) discusses the Dana-Farber algorithm for managing MM

All Medical News

ISH/BSH 2016 Abstracts and Posters: Results from the NCRI Myeloma XI trial

Charlotte Pawlyn and John R Jones (both of Institute of Cancer Research, London) and Ruth de Tute, St James’s University Hospital, Leeds. by Maria Dalby: Quadruplet therapy with… read more.

All Medical News

ISH/BSH 2016: Professor Philippe Moreau from Nantes in France reviewed the rationale for the new diagnostic criteria and highlighted the gaps in current risk models for stratifying the risk of progression to MM… Also included article entitled ‘High-risk smouldering myeloma’

High-risk smouldering myeloma by Maria Dalby Professor Philippe Moreau, University Hospital Hôtel-Dieu, Nantes, France Subsequent to the publication of updated diagnostic criteria for MM in 2014,1 MM clinicians have… read more.

All Medical News

ISH/BSH 2016: Advances in our understanding of clonal evolution in MM: where are we now?

Professor Keith Stewart, Mayo Clinic, Scottsdale, AZ, USA. by Maria Dalby: The dramatic improvement in MM survival in the last 40 years is largely linked to the introduction… read more.